No valuation for StabiLux Biosciences is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($1.9M) and the funding record below are the closest available signals.
- ·The complete investor list: 12 names
- ·Watch StabiLux Biosciences: the Monday email on marks, rounds and moves
StabiLux Biosciences funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2024 | Seed Round | $554K | ▮ | ▮ |
Membership and data by Private Market View
How much has StabiLux Biosciences raised?
StabiLux Biosciences has raised $1.9 million in total; 1 of its rounds is on record. The largest on record was a $554,381 seed round in Apr 2024.
StabiLux Biosciences has filed 1 Form D with the SEC, most recently in May 2024 ($554,381 sold to 9 investors).
How StabiLux Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For StabiLux Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked about StabiLux Biosciences
- How much has StabiLux Biosciences raised?
- StabiLux Biosciences has raised $1.9M in total funding across 1 recorded rounds.
- When did StabiLux Biosciences last raise?
- StabiLux Biosciences last raised in Apr 2024 (Seed Round), raising $554K.